Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection

被引：12
|
作者：
Bi, Sheng [1 ]
Yao, Xin [2 ]
Huang, Cheng [1 ,3 ]
Zheng, Xia [4 ]
Xuan, Tianming [5 ]
Sheng, Jifang [1 ]
Xu, Kaijin [1 ]
Zheng, Beiwen [1 ,7 ]
Yang, Qing [6 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China
[3] Lihuili Hosp, Ningbo Med Ctr, Dept Resp Med, Ningbo, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Intens Care Unit, Hangzhou, Zhejiang, Peoples R China
[5] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiovasc, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Ctr Clin Lab, Hangzhou, Zhejiang, Peoples R China
[7] Chinese Acad Inspect & Quarantine, Inst Anim Quarantine, Beijing, Peoples R China
来源：
INFECTION | 2019年 / 47卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Carbapenem-resistance; KPC-2-producing Klebsiella pneumoniae; Tigecycline; Meropenem; Antagonistic effect; GENTAMICIN; POLYMYXIN; EFFICACY; THERAPY;
D O I：
10.1007/s15010-019-01274-w
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
IntroductionA woman infected by carbapenem-resistant Klebsiella pneumoniae is reported in this study.Case reportTigecycline and meropenem combination was used, and indeed, in vitro checkerboard synergy test confirmed the antagonism between the two antibiotics. Thus, meropenem was ceased and single high-dose tigecycline was successful against the infection. Subsequent experiments showed that the isolates of the KPC-2-producing K. pneumoniae ST11 clone caused the infection.ConclusionTherefore, tigecycline and meropenem combination should be used with caution.
引用
收藏
页码：497 / 500
页数：4
相关论文
共 50 条
  • [21] ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China
    Qi, Yan
    Wei, Zeqing
    Ji, Shujuan
    Du, Xiaoxing
    Shen, Ping
    Yu, Yunsong
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (02) : 307 - 312
  • [22] Tigecycline treatment of infection caused by KPC-producing Escherichia coli in a pediatric patient
    Du, Xiaoxing
    Fu, Ying
    Yu, Yunsong
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2013, 12
  • [23] Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae
    Cojutti, Piergiorgio
    Sartor, Assunta
    Righi, Elda
    Scarparo, Claudio
    Bassetti, Matteo
    Pea, Federico
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (10)
  • [24] Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay
    Pournaras, Spyros
    Vrioni, Georgia
    Neou, Evangelia
    Dendrinos, John
    Dimitroulia, Evangelia
    Poulou, Aggeliki
    Tsakris, Athanassios
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (03) : 244 - 247
  • [25] Meropenem/vaborbactam activity in vitro: a new option for Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae treatment
    Romanelli, Federica
    Stolfa, Stefania
    Morea, Anna
    Ronga, Luigi
    Prete, Raffaele Del
    Chironna, Maria
    Santacroce, Luigi
    Mosca, Adriana
    FUTURE MICROBIOLOGY, 2021, 16 (16) : 1261 - 1266
  • [26] Efficacy of tigecycline alone or in combination for experimental infections by KPC carbapenemase-producing Klebsiella pneumoniae
    Fergadaki, Sotiria
    Renieris, Georgios
    Machairas, Nikolaos
    Sabracos, Labros
    Droggiti, Dionyssia-Irene
    Misiakos, Evangelos
    Giamarellos-Bourboulis, Evangelos J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (03)
  • [27] Tigecycline treatment of infection caused by KPC-producing Escherichia coli in a pediatric patient
    Xiaoxing Du
    Ying Fu
    Yunsong Yu
    Annals of Clinical Microbiology and Antimicrobials, 12
  • [28] Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?
    Cojutti, Piergiorgio
    Sartor, Assunta
    Bassetti, Matteo
    Scarparo, Claudio
    Pea, Federico
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2018, 14 : 233 - 236
  • [29] Performance of polymyxin B Etest in a setting of high prevalence of KPC-producing Klebsiella pneumoniae
    Zavascki, Alexandre P.
    Magagnin, Cibele Massotti
    Wink, Priscila Lamb
    de Oliveira, Vanessa Pimentel
    Nunes, Aline Gabrielle
    Krummer, Thaysa Guglieri
    Aquino, Valerio Rodrigues
    Barth, Afonso Luis
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 40 - 42
  • [30] Antisense peptide nucleic acid inhibits the growth of KPC-producing Klebsiella pneumoniae strain
    da Silva, Kesia Esther
    Ribeiro, Suzana Meira
    Rossato, Luana
    dos Santos, Caroline Paes
    Preza, Sergio Espindola
    Cardoso, Marlon Henrique
    Franco, Octavio Luiz
    Migliolo, Ludovico
    Simionatto, Simone
    RESEARCH IN MICROBIOLOGY, 2021, 172 (4-5)
12345